SALKIND GENE purchased 29.6% of their position (50K shares) of UPEXI, INC. on the open market
Open‑market purchase worth $127.5K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/21/2025ACC: 0001477932-25-008535
Director10% Owner
+50K
Net shares
Net buyer
$127.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
50K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+50K
Price / share
$2.55
Trade value
$127.50K
% of position
29.6%
—
168.75K→218.75K
Total
Net shares
+50K
Net value
$127.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | — | P · Purchase | +50K | $2.55 | $127.50K | 29.6% | 168.75K | 218.75K |
| Total | +50K | $127.50K | ||||||
Derivative Transactions0
No derivative transactions reported